Insider trading

Period: 120 months Stock: LONA Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

35 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

35 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

35 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

35 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
35 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
35 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

35 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Litton Mark James PRESIDENT and CEO
Sold at will
$27.69K 5,156 at 5.37
8.2%
Not planned
4 Mar 2026
San Martin Javier CHIEF MEDICAL OFFICER
Sold at will
$9.24K 1,720 at 5.37
9.8%
Not planned
4 Mar 2026
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER
Sold at will
$7.30K 1,359 at 5.37
5.1%
Not planned
4 Mar 2026
Worthington Mark GENERAL COUNSEL and CCO
Sold at will
$7.13K 1,328 at 5.37
6.7%
Not planned
4 Mar 2026
Renninger Robert CHIEF FINANCIAL OFFICER
Sold at will
$4.87K 906 at 5.37
5.4%
Not planned
2 Jan 2026
Litton Mark James President and CEO
Sold at will
$17.79K 2,586 at 6.88
6.0%
Not planned
2 Jan 2026
San Martin Javier CHIEF MEDICAL OFFICER
Sold at will
$11.31K 1,644 at 6.88
13.9%
Not planned
2 Jan 2026
Worthington Mark General Counsel and CCO
Sold at will
$6.03K 876 at 6.88
5.9%
Not planned
2 Jan 2026
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER
Sold at will
$6.03K 876 at 6.88
4.1%
Not planned
2 Jan 2026
Renninger Robert Chief Financial Officer
Sold at will
$2.04K 297 at 6.88
2.3%
Not planned
1 Jul 2025
Litton Mark James President and CEO
Sold at will
$7.37K 25,123 at 0.29
7.2%
Not planned
1 Jul 2025
San Martin Javier CHIEF MEDICAL OFFICER
Sold at will
$3.18K 10,842 at 0.29
13.1%
Not planned
1 Jul 2025
Worthington Mark General Counsel and CCO
Sold at will
$2.50K 8,526 at 0.29
7.1%
Not planned
1 Jul 2025
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER
Sold at will
$2.50K 8,526 at 0.29
4.8%
Not planned
1 Jul 2025
Renninger Robert SVP, Finance and Accounting
Sold at will
$850.27 2,897 at 0.29
2.6%
Not planned
2 Jan 2025
Litton Mark James President and CEO
Sold at will
$14.11K 25,107 at 0.56
9.4%
Not planned
2 Jan 2025
San Martin Javier CHIEF MEDICAL OFFICER
Sold at will
$6.08K 10,826 at 0.56
23.2%
Not planned
2 Jan 2025
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER
Sold at will
$4.78K 8,510 at 0.56
6.1%
Not planned
2 Jan 2025
Worthington Mark General Counsel and CCO
Sold at will
$4.78K 8,510 at 0.56
9.2%
Not planned
2 Jan 2025
Renninger Robert VP of Finance
Sold at will
$1.62K 2,881 at 0.56
3.1%
Not planned
5 Sep 2024
Litton Mark James President and CEO
Sold at will
$2.85K 5,032 at 0.57
3.1%
Not planned
5 Sep 2024
Worthington Mark GENERAL COUNSEL
Sold at will
$1.43K 2,525 at 0.57
4.6%
Not planned
5 Sep 2024
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER
Sold at will
$1.43K 2,525 at 0.57
2.7%
Not planned
5 Sep 2024
Lenington Rachel COO and CDO
Sold at will
$1.43K 2,525 at 0.57
10.8%
Not planned
5 Sep 2024
Gengos Andrew CFO and Chief Business Officer
Sold at will
$719.95 1,272 at 0.57
1.3%
Not planned
5 Jan 2024
Litton Mark James Chief Executive Officer
Sold at will
$14.03K 4,820 at 2.91
3.2%
Not planned
5 Jan 2024
Lenington Rachel Chief Operating Officer
Sold at will
$7.02K 2,412 at 2.91
15.3%
Not planned
5 Jan 2024
Worthington Mark General Counsel
Sold at will
$7.02K 2,412 at 2.91
6.5%
Not planned
5 Jan 2023
CHURCH KEVIN Chief Scientific Officer
Sold at will
$7.02K 2,412 at 2.91
2.9%
Not planned
5 Jan 2023
Gengos Andrew See Below
Sold at will
$3.52K 1,208 at 2.91
1.4%
Not planned
23 Jun 2022
Litton Mark James Chief Executive Officer
Sold, plan not stated
$21.41K 7,960 at 2.69
5.8%
23 Jun 2022
Lenington Rachel Chief Operating Officer
Sold, plan not stated
$11.28K 4,193 at 2.69
41.9%
23 Jun 2022
Worthington Mark General Counsel
Sold, plan not stated
$7.03K 2,614 at 2.69
12.0%
23 Jun 2022
CHURCH KEVIN Executive VP, Research
Sold, plan not stated
$7.03K 2,614 at 2.69
4.3%
23 Jun 2022
MILESON GLENNA Chief Financial Officer
Sold, plan not stated
$7.03K 2,614 at 2.69
2.3%
Showing 1–35 of 35.